These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 9696044

  • 1. The gene encoding the granulocyte colony-stimulating factor receptor is a target for deregulation in pre-B ALL by the t(1;19)-specific oncoprotein E2A-Pbx1.
    de Lau WB, Hurenkamp J, Berendes P, Touw IP, Clevers HC, van Dijk MA.
    Oncogene; 1998 Jul 30; 17(4):503-10. PubMed ID: 9696044
    [Abstract] [Full Text] [Related]

  • 2. EB-1, a tyrosine kinase signal transduction gene, is transcriptionally activated in the t(1;19) subset of pre-B ALL, which express oncoprotein E2a-Pbx1.
    Fu X, McGrath S, Pasillas M, Nakazawa S, Kamps MP.
    Oncogene; 1999 Sep 02; 18(35):4920-9. PubMed ID: 10490826
    [Abstract] [Full Text] [Related]

  • 3. The effects of siRNA-mediated inhibition of E2A-PBX1 on EB-1 and Wnt16b expression in the 697 pre-B leukemia cell line.
    Casagrande G, te Kronnie G, Basso G.
    Haematologica; 2006 Jun 02; 91(6):765-71. PubMed ID: 16769578
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. E2a/Pbx1 oncogene inhibits terminal differentiation but not myeloid potential of pro-T cells.
    Bourette RP, Grasset MF, Mouchiroud G.
    Oncogene; 2007 Jan 11; 26(2):234-47. PubMed ID: 16819510
    [Abstract] [Full Text] [Related]

  • 7. beta-catenin is involved in N-cadherin-dependent adhesion, but not in canonical Wnt signaling in E2A-PBX1-positive B acute lymphoblastic leukemia cells.
    Nygren MK, Døsen-Dahl G, Stubberud H, Wälchli S, Munthe E, Rian E.
    Exp Hematol; 2009 Feb 11; 37(2):225-33. PubMed ID: 19101069
    [Abstract] [Full Text] [Related]

  • 8. Oncoprotein E2A-Pbx1 immortalizes a myeloid progenitor in primary marrow cultures without abrogating its factor-dependence.
    Kamps MP, Wright DD.
    Oncogene; 1994 Nov 11; 9(11):3159-66. PubMed ID: 7936638
    [Abstract] [Full Text] [Related]

  • 9. Specific immunologic recognition of the tumor-specific E2A-PBX1 fusion-point antigen in t(1;19)-positive pre-B cells.
    Berendes P, Hoogeveen A, van Dijk M, van Denderen J, van Ewijk W.
    Leukemia; 1995 Aug 11; 9(8):1321-7. PubMed ID: 7643619
    [Abstract] [Full Text] [Related]

  • 10. Expression of the E2A-PBX1 fusion transcripts in t(1;19)(q23;p13) and der(19)t(1;19) at diagnosis and in remission of acute lymphoblastic leukemia with different B lineage immunophenotypes.
    Devaraj PE, Foroni L, Janossy G, Hoffbrand AV, Secker-Walker LM.
    Leukemia; 1995 May 11; 9(5):821-5. PubMed ID: 7769844
    [Abstract] [Full Text] [Related]

  • 11. [Acute T cells lymphoblastic leukemia with a t(1;19)(q23;p13) and E2A-PBX1 in an adult: one case report and literature review].
    He GS, Zhang XH, Yao L, Zhang R, Chen ZX, Wu DP, Sun AN, Jin ZM, Qiu HY, Hu XH.
    Zhonghua Xue Ye Xue Za Zhi; 2009 Oct 11; 30(10):675-7. PubMed ID: 19954663
    [Abstract] [Full Text] [Related]

  • 12. The highest affinity DNA element bound by Pbx complexes in t(1;19) leukemic cells fails to mediate cooperative DNA-binding or cooperative transactivation by E2a-Pbx1 and class I Hox proteins - evidence for selective targetting of E2a-Pbx1 to a subset of Pbx-recognition elements.
    Knoepfler PS, Kamps MP.
    Oncogene; 1997 May 29; 14(21):2521-31. PubMed ID: 9191052
    [Abstract] [Full Text] [Related]

  • 13. High incidence of proviral integrations in the Hoxa locus in a new model of E2a-PBX1-induced B-cell leukemia.
    Bijl J, Sauvageau M, Thompson A, Sauvageau G.
    Genes Dev; 2005 Jan 15; 19(2):224-33. PubMed ID: 15655112
    [Abstract] [Full Text] [Related]

  • 14. Expression of identical E2A/PBX1 fusion transcripts occurs in both pre-B and early pre-B immunological subtypes of childhood acute lymphoblastic leukemia.
    Izraeli S, Henn T, Strobl H, Ludwig WD, Kovar H, Haas OA, Harbott J, Bartram CR, Gadner H, Lion T.
    Leukemia; 1993 Dec 15; 7(12):2054-6. PubMed ID: 8255105
    [Abstract] [Full Text] [Related]

  • 15. Chimeric oncoprotein E2a-Pbx1 induces apoptosis of hematopoietic cells by a p53-independent mechanism that is suppressed by Bcl-2.
    Smith KS, Jacobs Y, Chang CP, Cleary ML.
    Oncogene; 1997 Jun 19; 14(24):2917-26. PubMed ID: 9205098
    [Abstract] [Full Text] [Related]

  • 16. An inhibitory switch derepressed by pbx, hox, and Meis/Prep1 partners regulates DNA-binding by pbx1 and E2a-pbx1 and is dispensable for myeloid immortalization by E2a-pbx1.
    Calvo KR, Knoepfler P, McGrath S, Kamps MP.
    Oncogene; 1999 Dec 23; 18(56):8033-43. PubMed ID: 10637514
    [Abstract] [Full Text] [Related]

  • 17. New E2A/PBX1 fusion transcript in a patient with t(1;19)(q23;p13) acute lymphoblastic leukemia.
    Numata S, Kato K, Horibe K.
    Leukemia; 1993 Sep 23; 7(9):1441-4. PubMed ID: 8103813
    [Abstract] [Full Text] [Related]

  • 18. ABCB1 over-expression and drug-efflux in acute lymphoblastic leukemia cell lines with t(17;19) and E2A-HLF expression.
    Baudis M, Prima V, Tung YH, Hunger SP.
    Pediatr Blood Cancer; 2006 Nov 23; 47(6):757-64. PubMed ID: 16206189
    [Abstract] [Full Text] [Related]

  • 19. Fusion with E2A alters the transcriptional properties of the homeodomain protein PBX1 in t(1;19) leukemias.
    LeBrun DP, Cleary ML.
    Oncogene; 1994 Jun 23; 9(6):1641-7. PubMed ID: 8183558
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.